FDA Approved: PANTOPRAZOLE — Supplemental Application (NorthStar RxLLC)

View source ↗

Summary

FDA approved a supplemental application for Pantoprazole (ANDA077619) filed by NorthStar RxLLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease
• Peptic Ulcer Disease
• Zollinger-ellison Syndrome

Drugs mentioned

• Pantoprazole (pantoprazole)

Snippet

SUPPL AP for PANTOPRAZOLE (PANTOPRAZOLE)